Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors in antipsychotic drug selection: tolerability considerations.

CNS spectrums - 1 Nov 2003

Nasrallah Henry A

Abstract excerpt

With the widespread use of atypical antipsychotics over the past several years, adverse metabolic effects have emerged as the most serious medical consequences of pharmacotherapy with some of these agents. Initially, weight gain and obesity were observed (especially with clozapine and olanzapine)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Bipolar Disorder
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Hyperlipidemias

Share to Risk Factors

Share to Schizophrenia

Share to Schizophrenic Psychology

Source

Identifiers

PMID: 14978455
DOI: 10.1017/s1092852900008166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14978455-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors in antipsychotic drug selection: tolerability considerations.PMID 14978455Read ↗

Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and DiscontinuationSemantic proximity Read ↗

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?Semantic proximity Read ↗

Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Semantic proximity Read ↗

Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.Semantic proximity Read ↗

Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.Semantic proximity Read ↗

Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatmentSemantic proximity Read ↗

Atypical antipsychotic (AAP)-induced metabolic toxicity : study of mechanisms, biomarkers and reversal strategiesSemantic proximity Read ↗

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.Semantic proximity Read ↗

Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants.Semantic proximity Read ↗

[Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake].Semantic proximity Read ↗

Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia.Semantic proximity Read ↗

Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6 genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.